No Data
Hong Kong stocks midday review | Hong Kong stocks have soared! The technology index surged more than 3%, network technology stocks, mainland real estate stocks, and dining stocks performed strongly. Meituan rose more than 3% again, and China Resources Lan
Most network technology stocks rose, Kuaishou-W up 6.10%, jd.com-SW up 5.37%; digital health stocks rose, ali health up 6.67%, Mediwellcare down 5.41%; dining stocks surged, jiumaojiu up 12.79%, xiabuxiabu up 6.49%.
Hong Kong stock buyback craze! The buyback amount exceeded 200 billion Hong Kong dollars by the end of the year, with Tencent Holdings leading the way.
Looking at the historical situation, tencent's repurchase efforts have been continuously increasing, with the repurchase amount reaching HKD 82.4 billion so far this year, already surpassing the full-year repurchase amount in 2023.
Hong Kong stocks turned around in the afternoon! Both Hang Seng Index and Technology Index reversed and rose, what happened?
Analysts believe that, under the current circumstances, both the Hong Kong stock market and the A-share market need policies as triggers. If China's stimulus policies can timely follow and exceed expectations after the Fed rate cut, the market may usher in a wave of prosperity.
Hong Kong biomedical stocks pull back, and Remegen drops more than 8%.
On September 16th, RemeGen fell more than 8%, BeiGene fell nearly 4%, genscript bio, tigermed, and wuxi bio fell more than 1%.
On September 12th, Tencent Holdings and Meituan-Dianping have both announced share repurchase plans. Tencent Holdings plans to repurchase shares at a cost of 1.001 billion Hong Kong dollars.
According to the disclosure documents of hkex on September 13, Tencent (00700.HK), Meituan-W (03690.HK), and other companies repurchased shares.① Tencent (00700.HK) repurchased 2.68 million ordinary shares on September 12, involving an amount of 1.001 billion Hong Kong dollars, with a repurchase price per share ranging from 376.6 Hong Kong dollars to 371 Hong Kong dollars. Since the authorization resolution was passed, the cumulative number of repurchased securities is 0.152 billion shares, accounting for 1.618% of the number of issued shares at the time of the ordinary resolution. ② Meituan-W (03690.HK) repurchased on September
Wuxi Bio announced on September 12th that it will spend approximately 55,999.2 million Hong Kong dollars to repurchase 4.805 million shares.
Wuxi Bio (02269) issued an announcement to repurchase approximately 55.9992 million Hong Kong dollars of shares on September 12, 2024, repurchasing 4.805 million shares at a repurchase price of 11.6-11.68 Hong Kong dollars per share.
No Data
No Data